missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 30171176

GIRK2 Antibody (KCNJ6/7559) [Janelia Fluor™ 669], Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals (Bio-Techne) NBP3-24131JF669

Product Code. 30171176

  • 5860.00 NOK / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

GIRK2 Monoclonal antibody specifically detects GIRK2 in Human samples. It is validated for Immunohistochemistry (Paraffin)
TRUSTED_SUSTAINABILITY
Specifications

Specifications

GIRK2
Monoclonal
Janelia Fluor 669
BIR1Kir3.2, G protein-activated inward rectifier potassium channel 2, GIRK-2, GIRK2KATP-2, hiGIRK2, Inward rectifier K(+) channel Kir3.2, inward rectifier potassium channel KIR3.2, KATP2human G protein coupled inward rectifier potassium channel 2 (hiGIRK2)10KCNJ7KIR3.2, MGC126596, Potassium channel, inwardly rectifying subfamily J member 6, potassium inwardly-rectifying channel, subfamily J, member 6
Recombinant fragment of human GIRK2 protein (exact sequence is proprietary)
0.1 mL
Lipid and Metabolism
3763
Store at 4°C in the dark.
IgG2 κ
Immunohistochemistry (Paraffin)
KCNJ6/7559
50mM Sodium Borate
Mouse
Protein A or G purified
RUO
Primary
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.